These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 603318)

  • 21. Lorcainide in patients with refractory ventricular tachyarrhythmia.
    Chesnie B; Lampert S; Podrid P; Lown B
    J Am Coll Cardiol; 1984 Jun; 3(6):1531-9. PubMed ID: 6715710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lorcainide for the treatment of refractory ventricular tachycardia: clinical and electrophysiologic results.
    Hanyok JJ; Kluger J; Chow MS; Fieldman A
    J Clin Pharmacol; 1987 Apr; 27(4):278-82. PubMed ID: 3680584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effect of lorcainide in patients taking digoxin.
    Giardina EG; Raby K; Saroff AL; Louie-Chu M
    J Clin Pharmacol; 1987; 27(5):378-83. PubMed ID: 3693581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of flecainide in the treatment of ventricular arrhythmia].
    Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
    Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of lorcainide on the ECG pattern and left ventricular function in a patient with recurrent ventricular tachycardia].
    Sniezek-Maciejewska M; Bryniarski L; Mazurek S; Dubiel JP
    Kardiol Pol; 1990; 33(9-10):28-31. PubMed ID: 2074642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of anti-arrhythmic efficacy of a domestic drug allapinin in patients with ischemic heart disease and cardiac arrhythmia].
    Zamotaev IuN; Kremnev IuA; Grinenko NA; Podshibiakin SE
    Klin Med (Mosk); 2003; 81(11):51-4. PubMed ID: 14689712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 34. Lorcainide infusion in the treatment of ventricular premature beats (VPB).
    Klotz U; Müller-Seydlitz PM; Heimburg P
    Eur J Clin Pharmacol; 1979 Aug; 16(1):1-6. PubMed ID: 499295
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lorcainid--electrophysiologic examinations of a new anti-arrhythmia agent].
    Gstöttner M; Ng CK; Gmeiner R
    Acta Med Austriaca; 1978; 5(4-5):137-8. PubMed ID: 756123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
    Aliot E; Baille N; Zannad F; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988
    [No Abstract]   [Full Text] [Related]  

  • 37. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].
    Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E
    G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Propafenon, a new anti-arrhythmic drug (author's transl)].
    Aldor E; Heeger H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1318-22. PubMed ID: 60209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias.
    Cowley AJ; Skene A; Stainer K; Hampton JR
    Int J Cardiol; 1993 Jul; 40(2):161-6. PubMed ID: 8349379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.